对于抗体 - 药物合物的谷氨可切割的阿佐烯链接剂
Mia Kapun1, Roshan Patel1, Mahri Park1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK. spring@ch.cam.ac.uk.
概括
研究人员开发了一种新的谷氨可切割连接器,用于抗体-药物合物 (ADC). 这种连接器使得癌细胞中的药物有效释放,同时在体内保持稳定,显示了针对癌症治疗的希望.
科学领域:
- 生物结合化学 生物结合化学
- 抗体与药物结合的发展.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 抗体-药物合物 (ADC) 是针对性癌症治疗的一个重要类别.
- 开发稳定和可切割的链接器对于ADC的有效性和安全性至关重要.
- 谷氨可切割连接剂为细胞内有效载荷释放提供了一个有希望的策略.
研究的目的:
- 为ADCs开发和表征一种含有亚博的可切割谷的新型链接剂.
- 为了评估链接器的稳定性和有效载荷释放特性.
- 评估使用该链接器的ADC对HER2阳性癌细胞的体外疗效.
主要方法:
- 基于亚博烯的链接剂的合成和表征.
- 在人体血中评估链接器稳定性.
- 在不同的谷氨酸度下对有效载荷释放的评估.
- 在体外细胞毒性测定使用HER2-阳性和HER2-阴性细胞系.
主要成果:
- 这种新型链接器在高氨条件下表现出有效的有效载荷释放.
- 链接剂在人体血中保持稳定,表明具有良好的药理动力学特性.
- 结合链接器的抗HER2ADC显示出强烈的体外细胞毒性.
- 与HER2阴性细胞相比,ADC对HER2阳性细胞系表现出选择性活性.
结论:
- 开发的含有亚博的可切割谷氨连接器是抗体-药物联合体设计的一个有前途的组件.
- 这种链接器可以促进向药物输送和释放到癌细胞中.
- 连接器的稳定性和选择性有效载荷释放有助于新型ADC疗法的潜力.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
803
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
803
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
869
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
869
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Phase II Conjugation Reactions: Overview
747
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
747
Antibody Structure
65.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.2K


